Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CmCR 186. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.